The Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 2024

Table of Contents

Chapter 1: Executive Summary

• Introduction
• Scope and Methodology
• Size and Growth of the Market
  • Table 1-1: Global POC Test Market, 2023-2028 (in millions $ at manufacturer level)
• Trends Affecting the Market
• Competitive Outlook
• Market Conclusions
• Conclusion One - POC market transformed by technological progress
• Conclusion Two - POC Molecular Diagnostics continue making inroads
• Conclusion Three - Prevention and early detection at nexus of POC development
• Conclusion Four - Wearables continue to influence POC market
• Conclusion Four - Test cost will continue to be an issue worldwide
• Conclusion Five - Rising demand will drive POC market in RoW markets
• Conclusion Six - New venues - urgent & retail care
• Conclusion Seven - COVID-19's Positive Effect
• Conclusion Eight - Insurance coverage for OTC COVID-19 testing
• Conclusion Nine - New Opportunities in POC Infectious Disease Testing
• Conclusion Ten - Supply Chain Delays
• Conclusion Eleven - Multiplex Testing Explodes
• Conclusion Twelve - AI Making Inroads into POC
• Conclusion Thirteen - Stand-alone ER/Urgent Centers Gain Acceptance
• Conclusion Fourteen - Digital Diagnostics and POC
• Conclusion Fifteen - Microfluidics Gaining Ground in POC

Chapter 2: Introduction and Overview

• Point-of-Care Diagnostics Testing
• Industry Regulations
• Types of CLIA Certificates
• POC Industry Drivers
• Patient focused drivers
• Medical/Healthcare related drivers
• Technology drivers
• Economic drivers
• Other drivers
• POC Industry Challenges
• POC Test Types
• Blood
• Urine
• Saliva
• Hair
• Optical Technologies
• Breath
• Conditions Evaluated by POC Diagnostic Testing
• Cancer
  • Colorectal Cancer
  • Prostate Cancer
• Cardiovascular Disease
• Diabetes
• Drug Abuse
• Infectious Disease
  • Herpes
  • HTLV
  • Respiratory Syncytial Virus
  • Hepatitis
  • Lyme Disease
  • Babesiosis
  • Gonorrhea, Syphilis and Chlamydia
  • Trichomonas Vaginalis
  • HIV/AIDS
  • Helicobacter Pylori
  • Influenza
  • Coronavirus
  • Mononucleosis
  • Streptococcus
• Osteoporosis
• Pregnancy and Fertility

Chapter 3: POC Blood Glucose Tests

• Types of Blood Glucose Testing
• Fasting Blood Sugar (FBS)
• 2-Hour Postprandial Blood Sugar (PPBS)
• Random Blood Sugar
• Glucose Tolerance Test
• Glucose Urine Test
• Glycated Hemoglobin (HbA1c)
• Products
• Blood Glucose Self-Testing
  • Table 3-1: Selected Glucose Self-Test Meter Innovations
  • Table 3-2: Selected Apps and Glucose Management IT
• Continuous Self-Testing
• Glycated Hemoglobin Tests
  • Table 3-3: Selected POC HbA1c Devices
• Professional
• Market Size and Growth
  • Table 3-4: Global POC Glucose (including CGM and HbA1c) Testing Market Analysis, 2023-2028 (in millions $ at the manufacturer's level)
  • Table 3-5: Global POC Diabetes Sales, by Test Category, 2023-2028 (Glucose, Self-test; Glucose, professional; Glucose, continuous; HbA1c, POC; TOTAL; $ millions)
• Regional Analysis
  • Figure 3-1: POC Blood Glucose Testing Regional Market Analysis, 2023 (%)
• POC Glucose Self-Testing
  • Table 3-6: Global POC Glucose Self-Testing Market (excludes continuous glucose devices), 2023-2028 (in millions $ at manufacturer level)
  • POC Continuous Glucose Self-Testing
  • Table 3-7: Global POC Continuous Glucose Self-Testing Market, 2023-2028 (in millions $ at manufacturer level)
• POC Glucose Professional Testing
  • Table 3-8: Global POC Glucose Professional Testing Market (excludes HbA1c testing), 2023-2028 (in millions $ at manufacturer level)
  • POC HbA1c Testing
  • Table 3-9: Global POC Glucose HbA1c Professional Testing Market, 2023-2028 (in millions $ at manufacturer level)
• Competitive Analysis
  • Table 3-10: Global POC Blood Glucose Testing Market (BGM, CGM,HbA1c) Revenues and Market Share of Leading Suppliers, 2023 (in millions $)
  • Figure 3-2: Global POC Glucose Test Manufacturers, by Percent, 2023 (%)

Chapter 4: POC Blood and Electrolytes Testing Market

• Types of Blood and Electrolytes Tests
• Hemoglobin/Hematocrit
• WBC and Other
• Blood Gases
• Electrolytes
• Products
  • Table 4-1: Selected POC Hemoglobin and Hematocrit Systems, 2023
  • Table 4-2: Selected POC Hematology Analyzer Systems, 2023
• Market Size and Growth
  • Table 4-3: Global POC Blood and Electrolytes Testing (Blood Gases/Electrolytes, Hemoglobin/Hematocrit, WBC), Market Analysis, 2023-2028 (in millions $ at the manufacturer's level)
  • Table 4-4: Global POC Blood & Electrolytes Revenues, by Test Category, 2023-2028 ($ millions)
• Regional Analysis
  • Figure 4-1: POC Blood and Electrolytes Testing Regional Market (US, Europe, Japan, Rest of World) Analysis, 2023 (%)
• POC Blood and Electrolyte Self-Testing
  • Table 4-5: Global POC Blood and Electrolyte Self Testing Market Analysis, 2023-2028 (in millions $ at the manufacturer's level)
• POC Blood and Electrolyte Professional Testing
  • Table 4-6: Global POC Blood and Electrolyte Professional Testing Market Analysis, 2023-2028 (in millions $ at the manufacturer's level)
• Competitive Analysis
  • Table 4-7: Global POC Blood and Electrolyte Testing Market, Revenues and Market Share of Leading Suppliers, 2023 (in millions $)
  • Figure 4-2: Global POC Blood and Electrolyte Testing Market Manufacturers, by Percent, 2023 (%)

Chapter 5: POC Rapid Coagulation

• Products
  • Table 5-1: Selected POC Coagulation Test Innovations
• Platelet Testing
  • Table 5-2: Selected Platelet Activity Test Innovations
• Market Size and Growth
  • Table 5-3: Global Rapid Coagulation Testing Market Analysis, 2023-2028 (in millions $ at the manufacturer's level)
• Regional Analysis
  • Figure 5-1: POC Rapid Coagulation Testing Regional (US, Europe, Japan, Rest of World) Market Analysis, 2023 (%)
• POC Rapid Coagulation Self-Testing
  • Table 5-4: POC Rapid Coagulation Self-Testing Market Analysis, 2023-2028 (in millions $ at the manufacturer's level)
• POC Rapid Coagulation Professional Testing
  • Table 5-5: POC Rapid Coagulation Professional Testing Market Analysis, 2023-2028 (in millions $ at the manufacturer's level)
• Competitive Analysis
  • Table 5-6: Global POC Rapid Coagulation Testing Market, Revenues and Market Share of Leading Suppliers, 2023 (in millions $)
  • Figure 5-2: Global POC Rapid Coagulation Testing Market, Market Share of Leading Suppliers, 2023 (%)

Chapter 6: POC Rapid Cardiac Markers

• Products
• Market Size and Growth
  • Table 6-1: Total Rapid Cardiac Markers Tests Market Analysis, 2023-2028 (in millions $ at the manufacturer's level)
• Regional Analysis
  • Figure 6-1: POC Rapid Cardiac Markers Testing, Regional (US, Europe, Japan, Rest of World) Market Analysis, 2023 (%)
• Competitive Analysis
  • Table 6-2: Global POC Cardiac Markers Test Market, Revenues and Market Share of Leading Suppliers, 2023 (in millions $)
  • Figure 6-2: Global POC Cardiac Markers Test Manufacturers, by Percent, 2023 (%)

Chapter 7: POC Substance Abuse

• Overview
• Products
• Urine
• Oral
• Blood
• Hair
• Market Size and Growth
  • Table 7-1: Global POC Drugs of Abuse Testing (critical care, employment and criminal) Market Analysis, 2023-2028 (in millions $ at the manufacturer's level)
• Regional Analysis
  • Figure 7-1: POC Substance Abuse Testing Regional (US, Europe, Japan, Rest of World) Market Analysis, 2023 (%)
• POC Drugs of Abuse Self-Testing
  • Table 7-2: Global POC Drugs of Abuse Self Testing Market, 2023-2028 ($ millions at the manufacturer's level)
• POC Drugs of Abuse Professional Testing
  • Table 7-3: Global POC Drugs of Abuse Professional Testing Market Analysis, 2023-2028 (in millions $ at the manufacturer's level)
• Competitive Analysis
  • Table 7-4: Global POC Drugs of Abuse Testing Market, Revenues and Market Share of Leading Suppliers, 2023 (in millions $)
  • Figure 7-2: Global POC Drug of Abuse Testing Manufacturers, by Percent, 2023 (%)

Chapter 8: POC Pregnancy and Fertility Testing

• Products
  • Table 8-1: Selected Pregnancy and Fertility CLIA Waivers (Manufacturer and Instrument / Assay), Manufacturer's Instrument / Device / Assay
• Market Size and Growth
  • Table 8-2: Global POC Pregnancy and Fertility Testing Market Analysis, 2023-2028 (in millions $ at the manufacturer's level)
• Regional Analysis
  • Figure 8-1: POC Pregnancy and Fertility Testing Regional (US, Europe, Japan, Rest of World) Market Analysis, 2023 (%)
• POC Pregnancy and Fertility Self-Testing
  • Table 8-3: POC Pregnancy and Fertility Self-Testing Market Analysis, 2023-2028 (in millions $ at the manufacturer's level)
• POC Pregnancy and Fertility Professional Testing
  • Table 8-4: POC Pregnancy and Fertility Professional Testing Market Analysis, 2023-2028 (in millions $ at the manufacturer's level)
• Competitive Analysis
  • Table 8-5: Global POC Pregnancy and Fertility Testing Market, Revenues and Market Share of Leading Suppliers, 2023 (in millions $)
  • Figure 8-2 Global POC Pregnancy and Fertility Testing Manufacturers, by Percent, 2023 (%)

Chapter 9: POC Colon Cancer Screening/Fecal Occult Blood Testing

• Products
  • Table 9-1: Selected POC Colon Cancer Tests
• Market Size and Growth
  • Table 9-2: Global POC Colon Cancer Screening/Fecal Occult Blood Testing Market Analysis, 2023-2028 (in millions $ at the manufacturer's level)
• Regional Analysis
  • Figure 9-1: POC Colon Cancer Screening/FOB Testing Regional (US, Europe, Japan, Rest of World) Market Analysis, 2023 (%)
• POC Colon Cancer Screening/Fecal Occult Blood Self-Testing
  • Table 9-3: POC Colon Cancer Screening/Fecal Occult Blood Self-Testing Market Analysis, 2023-2028 (in millions $ at the manufacturer's level)
• POC Colon Cancer Screening/ Fecal Occult Blood Professional Testing
  • Table 9-4: POC Colon Cancer Screening/Fecal Occult Blood Professional Testing Market Analysis, 2023-2028 (in millions $ at the manufacturer's level)
• Competitive Analysis
  • Table 9-5: Global POC Colon Cancer Screening/Fecal Occult Blood Testing Market, Revenues and Market Share of Leading Suppliers, 2023 (in millions $)
  • Figure 9-2: Global POC Colon Cancer Screening/Fecal Occult Blood Testing Manufacturers, by Percent, 2023 (%)

Chapter 10: POC Infectious Disease Testing

• Products
• HIV and Hepatitis
• Respiratory
• STD/STI
• Tropical Diseases
• Lyme Disease
• TB
• Zika
• Anthrax
• Other Viruses
• Hospital Acquired Infections and Sepsis
  • Sepsis
  • Diff
    • Table 10-1: Selected Innovations in POC Infectious Disease Diagnostics
• COVID-19
  • Antigen
    • Table 10-2: Selected Antigen POC Home Immunoassay Tests for SARS-CoV-2
  • Serology
  • Molecular
    • Table 10-3: Selected Molecular POC Home Tests for SARS-CoV-2
• Market Size and Growth
  • Table 10-4: Global POC Infectious Disease (including COVID-19) Testing Market Analysis, 2023-2028 (in millions $ at the manufacturer's level)
• Regional Analysis
  • Figure 10-1: POC Infectious Disease (including COVID-19) Testing Regional (US, Europe, Japan, Rest of World) Market Analysis, 2023 (%)
• POC Infectious Disease Self-Testing
  • Table 10-5: POC Infectious Disease Self-Testing (including COVID-19) Market Analysis, 2023-2028 (in millions $ at the manufacturer's level)
• POC Infectious Disease Professional Testing
  • Table 10-6: POC Infectious Disease (including COVID-19) Professional Testing Market Analysis, 2023-2028 (in millions $ at the manufacturer's level)
• POC Infectious Disease Testing by Disease Type
  • Table 10-7: Global POC Infectious Disease Revenues and Percent of Infectious Disease Market, by Disease Type, 2023 (in millions $)
  • Figure 10-2: Global POC Infectious Disease (COVID-19, Influenza, HIV, STD, Hepatitis, Malaria, C. Diff, coli, H. pylori, Home, Others), Percent by Disease Type, 2023 (%)
• Competitive Analysis
  • Table 10-8: Global POC Infectious Disease including COVID-19 Testing Market, Revenues and Market Share of Leading Suppliers, 2023 (in millions $)
  • Figure 10-3: Global POC Infectious Disease Test Manufacturers, by Percent, 2023 (%)

Chapter 11: POC Lipid Testing

• Products
• Market Size and Growth
  • Table 11-1: Global POC Lipid Testing Market Analysis, 2023-2028 (in millions $ at the manufacturer's level)
• Regional Analysis
  • Figure 11-1: POC Lipid Testing Regional (US, Europe, Japan, Rest of World) Market Analysis, 2023 (%)
• POC Lipid Self-Testing
  • Table 11-2: POC Lipid Self-Testing Market Analysis, 2023-2028 (in millions $ at the manufacturer's level)
• POC Lipid Professional Testing
  • Table 11-3: POC Lipid Professional Testing Market Analysis, 2023-2028 (in millions $ at the manufacturer's level)
• Competitive Analysis
  • Table 11-4: Global POC Lipid Testing Market, Revenues and Market Share of Leading Suppliers, 2023 (in millions $)
  • Figure 11-2: Global POC Lipid Testing Manufacturers, by Percent, 2023 (%)

Chapter 12: POC Cancer Tumor Marker Testing

• Products
  • Table 12-1: Selected Companies Developing and/or Marketing POC Tests for Oncology Indications
• Market Size and Growth
  • Table 12-2: Global POC Cancer Testing Market Analysis, 2023-2028 (in millions $ at the manufacturer's level)
• Regional Analysis
  • Figure 12-1: POC Cancer Tumor Marker Testing Regional (US, Europe, Japan, Rest of World) Market Analysis, 2023 (%)
• Competitive Analysis
  • Table 12-3: Global POC Cancer Testing Market, Revenues and Market Share of Leading Suppliers, 2023 (in millions $)
  • Figure 12-2: Global POC Cancer Testing Manufacturers, by Percent, 2023 (%)

Chapter 13: POC Urine Testing

• Products
• Market Size and Growth
  • Table 13-1: Global POC Urine Testing Market Analysis, 2023-2028 (in millions $ at the manufacturer's level)
• Regional Analysis
  • Figure 13-1: POC Urine Testing Regional (US, Europe, Japan, Rest of World) Market Analysis, 2023 (%)
• POC Urine Self-Testing
  • Table 13-2: POC Urine Self-Testing Market Analysis, 2023-2028 (in millions $ at the manufacturer's level)
• POC Urine Test Professional Testing
  • Table 13-3: POC Urine Professional Testing Market Analysis, 2023-2028 (in millions $ at the manufacturer's level)
• Competitive Analysis
  • Table 13-4: Global POC Urine Testing Market, Revenues and Market Share of Leading Suppliers, 2023 (in millions $)
  • Figure 13-2: Global POC Urine Strip Testing Manufacturers, by Percent, 2023 (%)

Chapter 14: Miscellaneous POC Testing

• Microbiology
• TSH
• Allergy
• Autoimmune
• Others
• Market Size and Growth
  • Table 14-1: Global Miscellaneous POC Testing Market Analysis, 2023-2028 (in millions $ at the manufacturer's level)
  • Table 14-2: Global POC Miscellaneous Sales, by Test Category, 2023-2028 (Microbiology, TSH, Allergy, Autoimmune, Others TOTAL; $ millions)
• Regional Analysis
  • Figure 14-1: POC Miscellaneous Testing Regional (US, Europe, Japan, Rest of World) Market Analysis, 2023 (%)

Chapter 15: Issues and Trends

• Overview
• Wearables
  • Table 15-1: Selected Wearable Devices
• Mobile Healthcare Technologies
• Telehealth
• Telehealth eMed to Implement Home Test to Treat Program
• Patient-centered Healthcare
• Breath Test Advances
  • Table 15-2: Selected Disease Markers in Exhaled Breath
• Regulatory Hurdles
• Reimbursement Challenges
• PAMA
• Competition
• POC and Molecular Diagnostics
  • Table 15-3: Selected Market Available Molecular POC Diagnostic Platforms
• POC Biosensors and Microfluidics
  • Table 15-4: Selected FDA-Approved Microfluidic-based POC Tests 2023
  • Table 15-5: Selected Biochip and Biosensor Players, 2023
• China as a POC Market
• Emerging POC Technologies
• POC Connectivity
• COVID-19 Impact
• Multiplexed POC Testing
  • Figure 15-1: Multiplexed POC Testing Schematic
• The Emergence of Non-invasive Technologies
• Saliva and Swab
• Optical Techniques
• Near-infrared Scanning
• Volatolomics
• POC and Antibiotic Resistance Concern
• Artificial Intelligence in POC
• POC Future in Infectious Disease Diagnostics
• Supply Chain Delays
• Insurance Coverage for OTC Diagnostic Tests
• Stand-Alone Emergency Department/Urgent Care Centers Combine with POC Team in New Mexico
• Digital Diagnostics
• Microfluidics and POC

Chapter 16: Total Global POC Testing Market and Competitor Analysis

• Market Overview
  • Table 16-1: Global POC Test Market, 2023-2028 (in millions $ at manufacturer level)
• Market Analysis by Product Categories
  • Table 16-2: Global POC Testing Market Analysis, by Product Category, 2023 (in millions $)
• Market Analysis by Subcategory
• POC Self-Testing
  • Table 16-3: Global POC Self-Testing Market Analysis, by Product Category, 2023 (in millions $)
  • Figure 16-1: Global POC Self-Testing Market Analysis, by Product Category, 2023 (%)
• POC Professional Testing
  • Table 16-4: Global POC Professional Testing Market Analysis, by Product Subcategory, 2023 (in millions $)
  • Figure 16-2 : Global POC Professional Testing Market Analysis, by Product Subcategory, 2023 (%)
• POC Testing by End-Use
  • Figure 16-3: POC Testing, by End-user, 2023
• Market by Device Technology
  • Figure 16-4: Global POC Market, by Technology, by Sales, 2023, (%)
• Market Analysis by Country
• United States
  • Table 16-5: US POC Testing Market Analysis, 2023-2028 (in millions $ at the manufacturer's level)
• Europe
  • Table 16-6: Europe POC Testing Market Analysis, 2023-2028 (in millions $ at the manufacturer's level)
  • Germany
  • France
  • UK
  • Switzerland and Sweden
  • Other
    • Figure 16-5: Europe POC Testing Percentage Participation, by Country, 2023 (%)
• Japan
  • Table 16-7: Japan POC Testing Market Analysis, 2023-2028 (in millions $ at the manufacturer's level)
• Rest of World
  • Latin America
  • China
  • India
  • South Korea
  • Other RoW Countries
    • Table 16-8: Global POC Testing Market Analysis, by Rest of World Region/Country, 2023 (in millions $)
    • Figure 16-6: Global POC Testing Market Analysis, by Rest of World Region/Country, 2023 (%)
    • Table 16-9: Global POC Testing Analysis, by Region/Country, 2023 (in millions $)
    • Figure 16-7: Global POC Testing Market Analysis Percent, by Region/Country, 2023 (%)
• Competitive Analysis
  • Table 16-10: Global Top 10 POC Testing Market Revenues and Market Share of Leading Suppliers, 2023 (in millions $)
  • Figure 16-8: Global POC Testing Market Share, by Leading Suppliers, 2023 (%)

Chapter 17: Corporate Profiles

• Overview

• 1 Step Detect Associates, LLC
  • Table 17-1: 1-Step Detect Associates Corporate Summary
• Company Overview
• Products

• Abbott Laboratories
  • Table 17-2: Abbott Corporate Summary
• Company Overview
• Products
• COVID-19
• Performance Review
  • Table 17-3: Abbott Revenues 2020-2023 (in millions $)

• Abingdon Health Ltd.
  • Table 17-4: Abingdon Health Corporate Summary
• Company Overview
• Products
• COVID-19

• Access Bio, Inc.
  • Table 17-5: Access Bio Corporate Summary
• Company Overview
• Products
• COVID-19

• AccuBioTech Co, Ltd.
  • Table 17-6: AccuBioTech Corporate Summary
• Company Overview
• Products
• COVID-19

• ACON Laboratories, Inc
  • Table 17-7: ACON Laboratories Corporate Summary
• Company Overview
• Products
• COVID-19

• Aerscher Diagnostics, LLC
  • Table 17-8: Aerscher Diagnostics Corporate Summary
• Company Overview
• Products

• Alfa Scientific Designs, Inc
  • Table 17-9: Alfa Scientific Corporate Summary
• Company Overview
• Products
• COVID-19

• American Bio Medica Corporation
  • Table 17-10: American Bio Medica Corporate Summary
• Company Overview
• Products
• COVID-19

• ARKRAY, Inc.
  • Table 17-11: ARKRAY Corporate Summary
• Company Overview
• Products

• Artron Laboratories, Inc
  • Table 17-12: Artron Laboratories Corporate Summary
• Company Overview
• Products
• COVID-19

• Ascensia Diabetes Care Holdings AG
  • Table 17-13: Ascensia Diabetes Care Corporate Summary
• Company Overview
• Products

• Atlas Link Biotech Co., Ltd
  • Table 17-14: Atlas Link Biotech Corporate Summary
• Company Overview
• Products
• COVID-19

• Autobio Diagnostics Co., Ltd
  • Table 17-15: Autobio Diagnostics Corporate Summary
• Company Overview
• Products
• COVID-19

• Beckman Coulter, Inc
  • Table 17-16: Beckman Coulter Corporate Summary
• Company Overview
• Products
• COVID-19
• Company Financials
  • Table 17-17: Beckman Coulter Revenue, 2020-2023 ($ millions)

• Becton Dickinson (BD)
  • Table 17-18: BD Corporate Summary
• Company Overview
• Products
• COVID-19
• Company Financials
  • Table 17-19: BD Corporation Revenues, 2020-2023 ($ millions)

• Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
  • Table 17-20: Beijing Wantai Biological Pharmacy Enterprise Corporate Summary
• Company Overview
• Products
• COVID-19

• Bhat Bio-Tech India Private Ltd. (BBI)
  • Table 17-21: Bhat Bio-Tech India Private Corporate Summary
• Company Overview
• Products
• COVID-19

• binx health
  • Table 17-22: binx health Corporate Summary
• Company Overview
• Products
• COVID-19

• bioLytical Laboratories
  • Table 17-23: bioLytical Laboratories Corporate Summary
• Company Overview
• Products
• COVID-19

• BioMedomics, Inc.
  • Table 17-24: BioMedomics Corporate Summary
• Company Overview
• Products
• COVID-19

• Biomeme, Inc.
  • Table 17-25: Biomeme Corporate Summary
• Company Overview
• Products

• Biomerica, Inc.
  • Table 17-26: Biomerica Corporate Summary
• Company Overview
• Products
• Company Financials
  • Table 17-27: Biomerica Corporation Revenues, 2020-2023 ($ millions)

• bioMerieux SA
  • Table 17-28: bioMerieux SA Corporate Summary
• Company Overview
• Products
• COVID-19
• Company Financials
  • Table 17-29: bioMerieux Revenues, 2020-2023 ($ millions)

• Bio-Rad Laboratories Inc.
  • Table 17-30: Bio-Rad Labs Corporate Summary
• Company Overview
• Products
• Company Financials
  • Table 17-31: Bio-Rad Corporation Revenues, 2020-2023 ($ millions)

• Biosynex SA
  • Table 17-32: Biosynex SA Corporate Summary
• Company Overview
• Products

• Biotron Diagnostics, Inc.
  • Table 17-33: Biotron Diagnostics Corporate Summary
• Company Overview
• Products

• Boditech Med Inc.
  • Table 17-34: Boditech Med Corporate Summary
• Company Overview
• Products
• COVID-19

• Boson Biotech Co. Ltd.
  • Table 17-35: Boson Biotech Corporate Summary
• Company Overview
• Products
• COVID-19

• BTNX Inc.
  • Table 17-36: BTNX Corporate Summary
• Company Overview
• Products
• COVID-19

• Cepheid, Inc.
  • Table 17-37: Cephid Corporate Summary
• Company Overview
• Products
• COVID-19
• Performance Review
  • Table 17-38: Cepheid Revenues, 2020-2023 ($ millions)

• Chembio Diagnostics Systems, Inc.
  • Table 17-39: Chembio Diagnostic Corporate Summary
• Company Overview
• Products
• COVID-19

• Church & Dwight Co. Inc.
  • Table 17-40: Church & Dwight Corporate Summary
• Company Overview
• Products
• Performance Review
  • Table 17-41: Church and Dwight Revenues, 2020-2023 ($ millions)

• Clarity Diagnostics, LLC
  • Table 17-42: Clarity Diagnostics Corporate Summary
• Company Overview
• Products
• COVID-19

• Confirm Biosciences
  • Table 17-43: Confirm Biosciences Corporate Summary
• Company Overview
• Products
• COVID-19

• CTK Biotech, Inc.
  • Table 17-44: CTK Biotech Corporate Summary
• Company Overview
• Products
• COVID-19

• Cue Health
  • Table 17-45: Cue Health Corporate Summary
• Company Overview
• Products
• COVID-19

• Danaher Corporation
  • Table 17-46: Danaher Corporation Summary
• Company Overview
• Products

• Dexcom, Inc.
  • Table 17-47: Dexcom Corporate Summary
• Company Overview
• Products
• Performance Review
  • Table 17-48: Dexcom Revenues, 2020-2023 ($ millions)

• DIALAB GmbH
  • Table 17-49: DIALAB Corporate Summary
• Company Overview
• Products
• COVID-19

• DiaSys Diagnostic Systems GmbH (Mindray)
  • Table 17-50: DiaSys Diagnostic Systems Corporate Summary
• Company Overview
• Products
• COVID-19

• Diazyme Laboratories, Inc.
  • Table 17-51: Diazyme Laboratories Corporate Summary
• Company Overview
• Products
• COVID-19

• DNA Electronics Ltd. (DNAe)
  • Table 17-52: DNA Electronics Corporate Summary
• Company Overview
• Products

• Dr. Fooke-Achterrath Laboratorien GmbH
  • Table 17-53: Dr. Fooke-Achterrath Laboratorien Corporate Summary
• Company Overview
• Products
• COVID-19

• DxGen Corp.
  • Table 17-54: DxGen Corporate Summary
• Company Overview
• Products
• COVID-19

• Eiken Chemical Co. Ltd.
  • Table 17-55: Eiken Chemical Corporate Summary
• Company Overview
• Products
• COVID-19
• Performance Review
  • Table 17-56: Eiken Chemical Revenues, 2020-2023 ($ millions)

• EKF Diagnostics Holdings plc
  • Table 17-57: EKF Diagnostics Corporate Summary
• Company Overview
• Products

• ELITechGroup S.A.S.
  • Table 17-58: ELITechGroup Corporate Summary
• Company Overview
• Products
• COVID-19

• Eurobio Scientific
  • Table 17-59: Eurobio Scientific Corporate Summary
• Company Overview
• Products
• COVID-19

• Everlywell
  • Table 17-60: Everlywell Corporate Summary
• Company Overview
• Products
• COVID-19

• Exact Sciences
  • Table 17-61: Exact Sciences Corporate Summary
• Company Overview
• Products
• Performance Review
  • Table 17-62: Exact Sciences Revenues, 2020-2023 ($ millions)

• EY Laboratories
  • Table 17-63: EY Laboratories Corporate Summary
• Company Overview
• Products

• First Check Diagnostics LLC
  • Table 17-64: First Check Diagnostics Corporate Summary
• Company Overview
• Products

• GenBio
  • Table 17-65: GenBio Corporate Summary
• Company Overview
• Products

• Genedrive plc
  • Table 17-66: Genedrive Corporate Summary
• Company Overview
• Products
• COVID-19
• Performance Review
  • Table 17-67: Genedrive Revenues, 2020-2023 ($ millions)

• GeTein Biotech Inc.
  • Table 17-68: GeTein Corporate Summary
• Company Overview
• Products
• COVID-19

• Helena Laboratories
  • Table 17-69: Helena Laboratories Corporate Summary
• Company Overview
• Products

• Hemosure, Inc. (W.H.P.M)
  • Table 17-70: Hemosure Corporate Summary
• Company Overview
• Products

• HORIBA, Ltd.
  • Table 17-71: HORIBA Corporate Summary
• Company Overview
• Products
• Performance Review
  • Table 17-72: HORIBA Revenues, 2020-2023 ($ millions)

• Immune IQ
  • Table 17-73: Immune IQ Corporate Summary
• Company Overview
• Products

• Immunosciences Lab, Inc.
  • Table 17-74: Immunosciences Lab Corporate Summary
• Company Overview
• Products

• Immunostics, Inc.
  • Table 17-75: Immunostics Corporate Summary
• Company Overview
• Products
• COVID-19

• JAL Innovation PTE LTD.
  • Table 17-76: JAL Innovation Corporate Summary
• Company Overview
• Products

• Jant Pharmacal Corporation
  • Table 17-77: Jant Pharmacal Corporate Summary
• Company Overview
• Products

• 1.Mitra & Co Pvt. Ltd.
  • Table 17-78: J Mitra Corporate Summary
• Company Overview
• Products
• Covid-19

• Kypha
  • Table 17-79: Kypha Corporate Summary
• Company Overview
• Products

• LamdaGen Corporation
  • Table 17-80: LamdaGen Corporate Summary
• Company Overview
• Products
• COVID-19

• LifeScan, Inc.
  • Table 17-81: LifeScan Corporate Summary
• Company Overview
• Products

• LifeSign, LLC
  • Table 17-82: LifeSign Corporate Summary
• Company Overview
• Products
• COVID-19

• LightDeck Diagnostics
  • Table 17-83: LightDeck Diagnostics Corporate Summary
• Company Overview
• Products
• COVID-19

• LumiraDx UK Limited
  • Table 17-84: LumiraDx Corporate Summary
• Company Overview
• Products

• Macherey-Nagel GmbH & Co. KG
  • Table 17-85: Macherey-Nagel Corporate Summary
• Company Overview
• Products

• Medix Biochemica
  • Table 17-86: Medix Biochemica Corporate Summary
• Company Overview
• Products
• COVID-19

• MedMira, Inc.
  • Table 17-87: MedMira Corporate Summary
• Company Overview
• Products
• COVID-19
• Performance Review
  • Table 17-88: MedMira Revenues, 2020-2023 ($ thousands)

• Medtronic, Inc.
  • Table 17-89: Medtronic Corporate Summary
• Company Overview
• Products
• Performance Review
  • Table 17-90: Medtronic Revenues, 2020-2023 ($ millions)

• 1.Menarini Diagnostics srl.
  • Table 17-91: Menarini Diagnostics Corporate Summary
• Company Overview
• Products
• COVID-19

• Meridian Bioscience, Inc.
  • Table 17-92: Meridian Bioscience Corporate Summary
• Company Overview
• Products
• COVID-19

• MiCo BioMed
  • Table 17-93: MiCo BioMed Summary
• Company Overview
• Products

• Nano-Ditech Corporation
  • Table 17-94: Nano-Ditech Corporate Summary
• Company Overview
• Products
• COVID-19

• Nexus Dx Inc.
  • Table 17-95: Nexus Dx Corporate Summary
• Company Overview
• Products

• NG Biotech
  • Table 17-96: NG Biotech Corporate Summary
• Company Overview
• Products
• COVID-19

• Noble Medical, Inc.
  • Table 17-97: Noble Medical Corporate Summary
• Company Overview
• Products

• Nova Biomedical Corp.
  • Table 17-98: Nova Biomedical Corporate Summary
• Company Overview
• Products

• Oasis Diagnostics Corporation
  • Table 17-99: Oasis Diagnostics Corporate Summary
• Company Overview
• Products

• Operon S.A.
  • Table 17-100: Operon Corporate Summary
• Company Overview
• Products
• COVID-19

• OPKO Health, Inc.
  • Table 17-101: OPKO Health Corporate Summary
• Company Overview
• Products
• COVID-19
• Performance Review
  • Table 17-102: OPKO Health Revenues, 2020-2023 ($ millions)

• OraSure Technologies, Inc.
  • Table 17-103: OraSure Technologies Corporate Summary
• Company Overview
• Products
• COVID-19
• Performance Review
  • Table 17-104: OraSure Revenues, 2020-2023 ($ millions)

• PixCell Medical Technologies
  • Table 17-105: PixCell Corporate Summary
• Company Overview
• Products

• Polymedco, Inc.
  • Table 17-106: Polymedco Corporate Summary
• Company Overview
• Products

• Polymer Technologies, Inc. (PTS Diagnostics)
  • Table 17-107: Polymer Technologies Corporate Summary
• Company Overview
• Products
• COVID-19

• Preventis GmbH
  • Table 17-108: Preventis Corporate Summary
• Company Overview
• Products

• Princeton Biomeditech Corporation
  • Table 17-109: Princeton Biomeditech Corporate Summary
• Company Overview
• Products
• Covid-19

• QuantuMDx Group Limited
  • Table 17-110: QuantuMDx Group Corporate Summary
• Company Overview
• Products
• COVID-19

• QuidelOrtho Corporation
  • Table 17-111: QuidelOrtho Corporate Summary
• Company Overview
• Products
• COVID-19
• Performance Review
  • Table 17-112: QuidelOrtho Revenues, 2020-2023 ($ millions)

• Radiometer Medical A/S
  • Table 17-113: Radiometer Medical Corporate Summary
• Company Overview
• Products
• Performance Review
  • Table 17-114: Radiometer, 2020-2023 ($ millions)

• Randox Laboratories Limited
  • Table 17-115: Randox Labs Corporate Summary
• Company Overview
• Products
• COVID-19

• Response Biomedical Corp.
  • Table 17-116: Response Biomedical Corporate Summary
• Company Overview
• Products
• COVID-19

• Reszon Diagnostics International Sdn. Bhd.
  • Table 17-117: Reszon Diagnostics Corporate Summary
• Company Overview
• Products
• COVID-19

• Rheonix, Inc.
  • Table 17-118: Rheonix Corporate Summary
• Company Overview
• Products
• COVID-19

• Roche Diagnostic Corporation
  • Table 17-119: Roche Diagnostic Corporate Summary
• Company Overview
• Products
  • Table 17-120: Roche POC Marketed Products
• COVID-19
• Performance Review
  • Table 17-121: Roche Diagnostics, 2020-2023 ($ millions)

• Savyon Diagnostics
  • Table 17-122: Savyon Diagnostics Corporate Summary
• Company Overview
• Products
• COVID-19

• Sekisui Diagnostics LLC
  • Table 17-123: Sekisui Diagnostics Corporate Summary
• Company Overview
• Products
• COVID-19

• Siemens Healthineers GmbH
  • Table 17-124: Siemens Healthineers Corporate Summary
• Company Overview
• Products
• COVID-19
• Performance Review
  • Table 17-125: Siemens Healthineers, 2020-2023 ($ millions)

• Sysmex Corporation
  • Table 17-126: Sysmex Corporate Summary
• Company Overview
• Products
• Performance Review
  • Table 17-127: Sysmex, 2020-2023 ($ millions)

• TECHLAB, Inc.
  • Table 17-128: TECHLAB Corporate Summary
• Company Overview
• Products

• Trinity Biotech PLC
  • Table 17-129: Trinity Biotech Corporate Summary
• Company Overview
• Products
• COVID-19
• Performance Review
  • Table 17-130: Trinity Biotech Revenues, 2020-2023 ($ millions)

• Trividia Health
  • Table 17-131: Trividia Health Corporate Summary
• Company Overview
• Products

• Tulip Diagnostics Ltd. (Tulip Group)
  • Table 17-132: Tulip Diagnostics Corporate Summary
• Company Overview
• Product
• COVID-19

• VedaLab
  • Table 17-133: VedaLab Corporate Summary
• Company Overview
• Products
• COVID-19

• Werfen
  • Table 17-136: Werfen Corporate Summary
• Company Overview
• Products
• Performance Review
  • Table 17-137: Werfen, 2020-2023 ($ millions)